Cote d'Ivoire vs Equatorial Guinea: The number of people with susceptibility test result for rifampicin

Cote d'Ivoire
59.19
in 2021
Equatorial Guinea
54.36
in 2021
Cote d'Ivoire rank
111th
Equatorial Guinea rank
113th

The number of people with susceptibility test result for rifampicin over time

  • Cote d'Ivoire
  • Equatorial Guinea
0204060201720192021

How they compare

Cote d'Ivoire currently reports 59.19 against 54.36 in Equatorial Guinea, a difference of 4.83.

That makes Cote d'Ivoire's figure about 1.1 times Equatorial Guinea's.

The two have swapped places 2 times across 5 shared years of data; in 2017 it was Cote d'Ivoire ahead.

Cote d'Ivoire ranks 111th and Equatorial Guinea ranks 113th of 146 countries.

Across the 2 decades both report, Cote d'Ivoire averaged higher in 1 and Equatorial Guinea in 1.

Head to head by decade

Decade Cote d'Ivoire Equatorial Guinea Difference Ahead
2010s 23.43 4.02 19.41 Cote d'Ivoire
2020s 34.58 42.43 7.85 Equatorial Guinea

Averages of every year both report within each decade.

Frequently asked questions

Which has higher the number of people with susceptibility test result for rifampicin, Cote d'Ivoire or Equatorial Guinea?
Cote d'Ivoire, at 59.19 against 54.36 in Equatorial Guinea as of 2021.
What is the difference in the number of people with susceptibility test result for rifampicin between Cote d'Ivoire and Equatorial Guinea?
4.83, with Cote d'Ivoire ahead.
How many years of comparable data are there for Cote d'Ivoire and Equatorial Guinea?
5 years are reported by both, from 2017 to 2021.
How do Cote d'Ivoire and Equatorial Guinea rank globally for the number of people with susceptibility test result for rifampicin?
Cote d'Ivoire ranks 111th and Equatorial Guinea ranks 113th of 146 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Cote d'Ivoire vs Equatorial Guinea: The number of people with susceptibility test result for rifampicin. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 17 September 2026, from https://health.statizoid.com/compare/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among-2/cote-d-ivoire/equatorial-guinea/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among-2/cote-d-ivoire/equatorial-guinea/">Cote d'Ivoire vs Equatorial Guinea: The number of people with susceptibility test result for rifampicin</a> — Statizoid

About this data

Indicator
The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
148 places, 740 data points, 2017–2021
Last refreshed